North America COPD and Asthma Devices Market

North America COPD and Asthma Devices Market Overview

Increasing prevalence of respiratory diseases owing to the growing aging population and increasing pathogens in the environment has been the key factor driving the asthma and chronic obstructive pulmonary disease (COPD) market globally. Asthma & COPD are chronic respiratory diseases that are either genetically acquired or caused due to several environmental factors. These diseases are supposed to be non-curable, but may be controlled to a great extent with proper on-time diagnosis. The North America market for Asthma & COPD has been analyzed on the basis of drugs and devices used for these diseases. Key drugs employed for control and diagnosis of asthma and COPD may be classified on the basis of their types which include bronchodilators, leukotriene antagonists, mast cell stabilizers and immunosuppressants.

North America COPD and Asthma Devices Market Highlights

The report highlights the adoption of COPD & Asthma Devices in North America. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The countries included in the report are U.S, Canada, Mexico and Rest of North America.

 North America COPD and Asthma Devices Market Key Companies

Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.

North America COPD and Asthma Devices Market Segmentation

North America COPD & Asthma Devices, By Product Type

• North America COPD & Asthma Devices Market
  • North America COPD & Asthma Inhaler Market
    • North America COPD & Asthma Dry Powder Inhalers (DPIs) Market
    • North America COPD & Asthma Metered Dose Inhalers (MDIs) Market
    • North America COPD & Asthma Soft Mist Inhalers (SMIs) Market
  • North America COPD & Asthma Nebulizer Market
    • North America COPD & Asthma Pneumatic Nebulizers Market
    • North America COPD & Asthma Ultrasonic Nebulizer Market
    • North America COPD & Asthma Mesh Nebulizer Market

North America COPD & Asthma Devices Market, By Country

• North America
  • S
  • Mexico
  • Canada
  • Rest of North America

Unique Offerings from KBV Research

• Exhaustive coverage of North America COPD and Asthma Devices Market
• Highest number of market tables (1079 Tables, 573 Pages)
• Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
• Subscription based model available
• Free of cost quarterly updates
• Free of cost automatic pdf report generation
• Guaranteed best price
• Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition

1.2 Objectives

1.3 Market Scope

1.4 Segmentation

1.4.1 North America COPD & Asthma Devices, By Product Type

1.4.2 North America COPD & Asthma Devices Market, By Country

1.5 Research Methodology

Chapter 2. North America COPD and Asthma Devices Market Overview

2.1 Introduction

2.2 Key Influencing Factors

2.3 North America COPD & Asthma Device Market

Chapter 3. North America COPD and Asthma Device Market – By Product Type

3.1 North America COPD & Asthma Inhaler Market

3.1.1 North America COPD & Asthma Inhaler Market – By Product Type

3.1.1.1.1 North America COPD & Asthma Dry Powder Inhalers (DPIs) Market

3.1.1.1.2 North America COPD & Asthma Metered Dose Inhalers (MDIs) Market

3.1.1.1.3 North America COPD & Asthma Soft Mist Inhalers (SMIs) Market

3.1.1.1.4 North America COPD & Asthma Inhaler Market – By Country

3.1.1.1.5 North America COPD & Asthma Dry Powder Inhalers (DPIs) Market

3.1.1.1.6 North America COPD & Asthma Metered Dose Inhalers (MDIs) Market

3.1.1.1.7 North America COPD & Asthma Soft Mist Inhalers (MDIs) Market

3.2 North America COPD & Asthma Nebulizer Market

3.2.1 North America COPD & Asthma Nebulizer Market – By Type

3.2.1.1.1 North America COPD & Asthma Pneumatic Nebulizers Market

3.2.1.1.2 North America COPD & Asthma Ultrasonic Nebulizer Market – By Country

3.2.1.1.3 North America COPD & Asthma Mesh Nebulizer Market- By Country

3.2.1.2 North America COPD & Asthma Nebulizer Market – By Type

3.2.1.3 North America COPD & Asthma Nebulizer Market – By Country

3.2.1.4 North America COPD & Asthma Pneumatic Nebulizer Market

3.2.1.5 North America COPD & Asthma Ultrasonic Nebulizer Market

3.2.1.6 North America COPD & Asthma Mesh Nebulizer Market

Chapter 4. North America COPD & Asthma Device Market – By Country

4.1.1 U.S COPD and Asthma Devices Market

4.1.1.1 U.S COPD and Asthma Devices Market – By Product Type

4.1.1.1.1 U.S COPD and Asthma Inhalers Market

4.1.1.1.2 U.S COPD and Asthma Nebulizers Market

4.1.2 Canada COPD and Asthma Devices Market

4.1.2.1 Canada COPD and Asthma Devices Market – By Product Type

4.1.2.1.1 Canada COPD and Asthma Inhalers Market – By Product Type

4.1.2.1.2 Canada COPD and Asthma Nebulizers Market

4.1.3 Mexico COPD and Asthma Devices Market

4.1.3.1 Mexico COPD and Asthma Devices Market – By Product Type

4.1.3.1.1 Mexico COPD and Asthma Inhalers Market

4.1.3.1.2 Mexico COPD and Asthma Nebulizers Market – By Product Type

4.1.4 Rest of North America COPD and Asthma Devices Market

4.1.4.1 Rest of North America COPD and Asthma Devices Market – By Product Type

4.1.4.1.1 Rest of North America COPD and Asthma Inhalers Market

4.1.4.1.2 Rest of North America COPD and Asthma Nebulizers Market

Chapter 5. Company Profiles

5.1 Glaxosmithcline PLC

5.1.1 Company Overview

5.1.2 Financial Analysis

5.1.3 Segmental Analysis

5.1.4 Research & Development

5.2 Novartis International AG

5.2.1 Company Overview

5.2.2 Financial Analysis

5.2.3 Segmental Analysis

5.2.4 Research & Development

5.3 Merck & Co., Inc.

5.3.1 Company Overview

5.3.2 Financial Analysis

5.3.3 Segmental Analysis

5.3.4 Research & Development

5.4 AstraZeneca Plc

5.4.1 Company Overview

5.4.2 Financial Analysis

5.4.3 Segmental Analysis

5.4.4 Research & Development

5.5 3M Healthcare

5.5.1 Company Overview

5.5.2 Financial Analysis

5.5.3 Segmental Analysis

5.5.4 Research & Development

5.6 GF Health Products, Inc

5.6.1 Company Overview

5.7 Sunovion Pharmaceuticals Inc.

5.7.1 Company Overview

5.8 Smith Medicals, Inc.

5.8.1 Company Overview

5.8.2 Financial Analysis

5.8.3 Segmental Analysis

5.9 Baxter International

5.9.1 Company Overview

5.9.2 Financial Analysis

5.9.3 Segmental Analysis

5.9.4 Research & Development

5.1 Koninklijke Philips N.V.

5.10.1 Company Overview

5.10.2 Financial Analysis

5.10.3 Segmental Analysis

5.10.4 Research & Development

List of Tables

TABLE 1 NORTH AMERICA COPD & ASTHMA DEVICE MARKET ($MILLION): 2012-2015

TABLE 2 NORTH AMERICA COPD AND ASTHMA DEVICES MARKET ($MILLION): 2016-2022

TABLE 3 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($MILLION): 2012-2015

TABLE 4 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($MILLION): 2016-2022

TABLE 5 NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($MILLION): 2012-2015

TABLE 6 NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($MILLION): 2016-2022

TABLE 7 NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($MILLION): 2012-2015

TABLE 8 NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($MILLION): 2016-2022

TABLE 9 NORTH AMERICA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 10 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($MILLION): 2016-2022

TABLE 11 NORTH AMERICA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 12 NORTH AMERICA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 13 NORTH AMERICA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 14 NORTH AMERICA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 15 NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($MILLION): 2012-2015

TABLE 16 NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($MILLION): 2016-2022

TABLE 17 NORTH AMERICA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 18 NORTH AMERICA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 19 NORTH AMERICA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 20 NORTH AMERICA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 21 NORTH AMERICA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET- BY COUNTRY ($MILLION): 2012-2015

TABLE 22 NORTH AMERICA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET- BY COUNTRY ($MILLION): 2016-2022

TABLE 23 NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET – BY TYPE ($MILLION): 2012-2015

TABLE 24 NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET – BY TYPE ($MILLION): 2016-2022

TABLE 25 NORTH AMERICA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET- BY COUNTRY ($MILLION): 2012-2015

TABLE 26 NORTH AMERICA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET- BY COUNTRY ($MILLION): 2016-2022

TABLE 27 NORTH AMERICA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET- BY COUNTRY ($MILLION): 2012-2015

TABLE 28 NORTH AMERICA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET- BY COUNTRY ($MILLION): 2016-2022

TABLE 29 NORTH AMERICA COPD AND ASTHMA MESH NEBULIZER MARKET- BY COUNTRY ($MILLION): 2012-2015

TABLE 30 NORTH AMERICA COPD AND ASTHMA MESH NEBULIZER MARKET- BY COUNTRY ($MILLION): 2016-2022

TABLE 31 NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET- BY COUNTRY ($MILLION): 2012-2015

TABLE 32 NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET- BY COUNTRY ($MILLION): 2016-2022

TABLE 33 NORTH AMERICA COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($MILLION): 2012-2015

TABLE 34 NORTH AMERICA COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($MILLION): 2012-2015

TABLE 35 NORTH AMERICA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET- BY COUNTRY ($MILLION): 2012-2015

TABLE 36 NORTH AMERICA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET- BY COUNTRY ($MILLION): 2016-202

TABLE 37 NORTH AMERICA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET- BY COUNTRY ($MILLION): 2012-2015

TABLE 38 NORTH AMERICA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET- BY COUNTRY ($MILLION): 2016-2022

TABLE 39 NORTH AMERICA COPD AND ASTHMA MESH NEBULIZER MARKET- BY COUNTRY ($MILLION): 2012-2015

TABLE 40 NORTH AMERICA COPD AND ASTHMA MESH NEBULIZER MARKET- BY COUNTRY ($MILLION): 2016-2022

TABLE 41 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($MILLION): 2012-2015

TABLE 42 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($MILLION): 2016-2022

TABLE 43 U.S COPD & ASTHMA DEVICE MARKET: 2012-2015

TABLE 44 U.S COPD & ASTHMA DEVICE MARKET: (2016-2022)

TABLE 45 U.S COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2012-2015)

TABLE 46 U.S COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2016-2022)

TABLE 47 U.S COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2012-2015)

TABLE 48 U.S COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE(2016-2022)

TABLE 49 U.S COPD AND ASTHMA NEBULIZER MARKET (2016-2022)

TABLE 50 CANADA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2012-2015)

TABLE 51 CANADA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2016-2022)

TABLE 52 CANADA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2012-2015)

TABLE 53 CANADA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2016-2022)

TABLE 54 CANADA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2012-2015)

TABLE 55 CANADA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2016-2022)

TABLE 56 CANADA COPD AND ASTHMA NEBULIZER MARKET (2012-2015)

TABLE 57 CANADA COPD AND ASTHMA NEBULIZER MARKET (2016-2022)

TABLE 58 MEXICO COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2012-2016)

TABLE 59 MEXICO COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2016-2022)

TABLE 60 MEXICO COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2012-2015)

TABLE 61 MEXICO COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2016-2022)

TABLE 62 MEXICO COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2012-2015)

TABLE 63 MEXICO COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2016-2022)

TABLE 64 MEXICO COPD AND ASTHMA NEBULIZER MARKET (2012-2016)

TABLE 65 MEXICO COPD AND ASTHMA NEBULIZER MARKET (2016-2022)

TABLE 66 REST OF NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2012-2015)

TABLE 67 REST OF NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2016-2022)

TABLE 68 REST OF NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2012-2015)

TABLE 69 REST OF NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2016-2022)

TABLE 70 REST OF NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2012-2015)

TABLE 71 REST OF NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2016-2022)

TABLE 72 REST OF NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET (2012-2015)

TABLE 73 REST OF NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET (2016-2022)

TABLE 74 KEY INFORMATION – GLAXOSMITHCLINE PLC.

TABLE 75 KEY INFORMATION – NOVARTIS INTERNATIONAL AG.

TABLE 76 KEY INFORMATION – BIOTRONIK SE & CO. KG.

TABLE 77 KEY INFORMATION – ASTRAZENECA PLC.

TABLE 78 KEY INFORMATION – 3M HEALTHCARE.

TABLE 79 KEY INFORMATION – GF HEALTH PRODUCTS, INC.

TABLE 80 KEY INFORMATION – SUNOVION PHARMACEUTICALS INC.

TABLE 81 KEY INFORMATION – SMITH MEDICALS, INC.

TABLE 82 KEY INFORMATION – BAXTER INTERNATIONAL.

TABLE 83 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.